These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 34341790)

  • 1. Protection of human ACE2 transgenic Syrian hamsters from SARS CoV-2 variants by human polyclonal IgG from hyper-immunized transchromosomic bovines.
    Gilliland T; Liu Y; Li R; Dunn M; Cottle E; Terada Y; Ryckman Z; Alcorn M; Vasilatos S; Lundy J; Larson D; Wu H; Luke T; Bausch C; Egland K; Sullivan E; Wang Z; Klimstra WB
    bioRxiv; 2021 Jul; ():. PubMed ID: 34341790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transchromosomic bovine-derived anti-SARS-CoV-2 polyclonal human antibodies protects hACE2 transgenic hamsters against multiple variants.
    Gilliland T; Dunn M; Liu Y; Alcorn MDH; Terada Y; Vasilatos S; Lundy J; Li R; Nambulli S; Larson D; Duprex P; Wu H; Luke T; Bausch C; Egland K; Sullivan E; Wang Z; Klimstra WB
    iScience; 2023 Oct; 26(10):107764. PubMed ID: 37736038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunoglobulin from transchromosomic bovines hyperimmunized with SARS-CoV-2 spike antigen efficiently neutralizes viral variants.
    Liu Z; Wu H; Egland KA; Gilliland TC; Dunn MD; Luke TC; Sullivan EJ; Klimstra WB; Bausch CL; Whelan SPJ
    Hum Vaccin Immunother; 2022 Apr; 18(2):1940652. PubMed ID: 34228597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-HFRS Human IgG Produced in Transchromosomic Bovines Has Potent Hantavirus Neutralizing Activity and Is Protective in Animal Models.
    Perley CC; Brocato RL; Wu H; Bausch C; Karmali PP; Vega JB; Cohen MV; Somerville B; Kwilas SA; Principe LM; Shamblin J; Chivukula P; Sullivan E; Hooper JW
    Front Microbiol; 2020; 11():832. PubMed ID: 32508764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Convalescent human IgG, but not IgM, from COVID-19 survivors confers dose-dependent protection against SARS-CoV-2 replication and disease in hamsters.
    King HAD; Dussupt V; Mendez-Rivera L; Slike BM; Tran U; Jackson ND; Barkei E; Zemil M; Tourtellott-Fogt E; Kuklis CH; Soman S; Ahmed A; Porto M; Kitajewski C; Spence B; Benetiene D; Wieczorek L; Kar S; Gromowski G; Polonis VR; Krebs SJ; Modjarrad K; Bolton DL
    Front Immunol; 2023; 14():1138629. PubMed ID: 37026013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo.
    Luke T; Wu H; Zhao J; Channappanavar R; Coleman CM; Jiao JA; Matsushita H; Liu Y; Postnikova EN; Ork BL; Glenn G; Flyer D; Defang G; Raviprakash K; Kochel T; Wang J; Nie W; Smith G; Hensley LE; Olinger GG; Kuhn JH; Holbrook MR; Johnson RF; Perlman S; Sullivan E; Frieman MB
    Sci Transl Med; 2016 Feb; 8(326):326ra21. PubMed ID: 26888429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The B.1.427/1.429 (epsilon) SARS-CoV-2 variants are more virulent than ancestral B.1 (614G) in Syrian hamsters.
    Carroll T; Fox D; van Doremalen N; Ball E; Morris MK; Sotomayor-Gonzalez A; Servellita V; Rustagi A; Yinda CK; Fritts L; Port JR; Ma ZM; Holbrook M; Schulz J; Blish CA; Hanson C; Chiu CY; Munster V; Stanley S; Miller CJ
    bioRxiv; 2021 Aug; ():. PubMed ID: 34462750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of SARS-CoV-2 B.1.1.28.2 (P2) variant and pathogenicity comparison with D614G variant in hamster model.
    Yadav P; Mohandas S; Sarkale P; Nyayanit D; Shete A; Sahay R; Potdar V; Baradkar S; Gupta N; Sapkal G; Abraham P; Panda S; Bhargava B
    J Infect Public Health; 2022 Feb; 15(2):164-171. PubMed ID: 34959053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infection and vaccine-induced neutralizing antibody responses to the SARS-CoV-2 B.1.617.1 variant.
    Edara VV; Lai L; Sahoo MK; Floyd K; Sibai M; Solis D; Flowers MW; Hussaini L; Ciric CR; Bechnack S; Stephens K; Mokhtari EB; Mudvari P; Creanga A; Pegu A; Derrien-Colemyn A; Henry AR; Gagne M; Graham BS; Wrammert J; Douek DC; Boritz E; Pinsky BA; Suthar MS
    bioRxiv; 2021 May; ():. PubMed ID: 34013272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants.
    Wu K; Werner AP; Moliva JI; Koch M; Choi A; Stewart-Jones GBE; Bennett H; Boyoglu-Barnum S; Shi W; Graham BS; Carfi A; Corbett KS; Seder RA; Edwards DK
    bioRxiv; 2021 Jan; ():. PubMed ID: 33501442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single intranasal or intramuscular immunization with chimpanzee adenovirus vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters.
    Bricker TL; Darling TL; Hassan AO; Harastani HH; Soung A; Jiang X; Dai YN; Zhao H; Adams LJ; Holtzman MJ; Bailey AL; Case JB; Fremont DH; Klein R; Diamond MS; Boon ACM
    bioRxiv; 2020 Dec; ():. PubMed ID: 33299991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody Preparations from Human Transchromosomic Cows Exhibit Prophylactic and Therapeutic Efficacy against Venezuelan Equine Encephalitis Virus.
    Gardner CL; Sun C; Luke T; Raviprakash K; Wu H; Jiao JA; Sullivan E; Reed DS; Ryman KD; Klimstra WB
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28468884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infection and mRNA-1273 vaccine antibodies neutralize SARS-CoV-2 UK variant.
    Edara VV; Floyd K; Lai L; Gardner M; Hudson W; Piantadosi A; Waggoner JJ; Babiker A; Ahmed R; Xie X; Lokugamage K; Menachery V; Shi PY; Suthar MS
    medRxiv; 2021 Feb; ():. PubMed ID: 33564782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies Targeting Two Epitopes in SARS-CoV-2 Neutralize Pseudoviruses with the Spike Proteins from Different Variants.
    Yang CH; Li HC; Lee WH; Lo SY
    Pathogens; 2021 Jul; 10(7):. PubMed ID: 34358019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and Transmissibility.
    Chan JF; Zhang AJ; Yuan S; Poon VK; Chan CC; Lee AC; Chan WM; Fan Z; Tsoi HW; Wen L; Liang R; Cao J; Chen Y; Tang K; Luo C; Cai JP; Kok KH; Chu H; Chan KH; Sridhar S; Chen Z; Chen H; To KK; Yuen KY
    Clin Infect Dis; 2020 Dec; 71(9):2428-2446. PubMed ID: 32215622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern.
    Deshpande A; Harris BD; Martinez-Sobrido L; Kobie JJ; Walter MR
    Front Immunol; 2021; 12():691715. PubMed ID: 34149735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.
    Weisblum Y; Schmidt F; Zhang F; DaSilva J; Poston D; Lorenzi JCC; Muecksch F; Rutkowska M; Hoffmann HH; Michailidis E; Gaebler C; Agudelo M; Cho A; Wang Z; Gazumyan A; Cipolla M; Luchsinger L; Hillyer CD; Caskey M; Robbiani DF; Rice CM; Nussenzweig MC; Hatziioannou T; Bieniasz PD
    bioRxiv; 2020 Jul; ():. PubMed ID: 32743579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains.
    Diamond M; Chen R; Winkler E; Case J; Aziati I; Bricker T; Joshi A; Darling T; Ying B; Errico J; Shrihari S; VanBlargan L; Xie X; Gilchuk P; Zost S; Droit L; Liu Z; Stumpf S; Wang D; Handley S; Stine W; Shi PY; Garcia-Knight M; Andino R; Chiu C; Ellebedy A; Fremont D; Whelan S; Crowe J; Purcell L; Corti D; Boon A
    Res Sq; 2021 Apr; ():. PubMed ID: 34013259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells.
    Cao Y; Su B; Guo X; Sun W; Deng Y; Bao L; Zhu Q; Zhang X; Zheng Y; Geng C; Chai X; He R; Li X; Lv Q; Zhu H; Deng W; Xu Y; Wang Y; Qiao L; Tan Y; Song L; Wang G; Du X; Gao N; Liu J; Xiao J; Su XD; Du Z; Feng Y; Qin C; Qin C; Jin R; Xie XS
    Cell; 2020 Jul; 182(1):73-84.e16. PubMed ID: 32425270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2.
    Huang Q; Ji K; Tian S; Wang F; Huang B; Tong Z; Tan S; Hao J; Wang Q; Tan W; Gao GF; Yan J
    Nat Commun; 2021 Feb; 12(1):776. PubMed ID: 33536425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.